State Street’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,648,078
| Closed | -$310M | – | 3946 |
|
|
2020
Q3 | $310M | Sell |
3,648,078
-621,583
| -15% | -$31.4M | 0.02% | 557 |
|
|
2020
Q2 | $151M | Sell |
4,269,661
-2,806,049
| -40% | -$82M | 0.01% | 757 |
|
|
2020
Q1 | $95.4M | Buy |
7,075,710
+293,759
| +4% | +$4.94M | 0.01% | 886 |
|
|
2019
Q4 | $144M | Buy |
6,781,951
+191,775
| +3% | +$3.38M | 0.01% | 839 |
|
|
2019
Q3 | $87.4M | Sell |
6,590,176
-1,590,949
| -19% | -$23.4M | 0.01% | 1086 |
|
|
2019
Q2 | $113M | Buy |
8,181,125
+1,105,388
| +16% | +$16.6M | 0.01% | 955 |
|
|
2019
Q1 | $136M | Buy |
7,075,737
+1,542,951
| +28% | +$24.9M | 0.01% | 835 |
|
|
2018
Q4 | $79M | Sell |
5,532,786
-182,649
| -3% | -$3.63M | 0.01% | 1045 |
|
|
2018
Q3 | $119M | Buy |
5,715,435
+388,857
| +7% | +$9.21M | 0.01% | 959 |
|
|
2018
Q2 | $126M | Sell |
5,326,578
-996,270
| -16% | -$20M | 0.01% | 889 |
|
|
2018
Q1 | $92.4M | Sell |
6,322,848
-74,045
| -1% | -$1.21M | 0.01% | 1059 |
|
|
2017
Q4 | $103M | Buy |
6,396,893
+1,645,878
| +35% | +$19.4M | 0.01% | 996 |
|
|
2017
Q3 | $66.4M | Sell |
4,751,015
-67,832
| -1% | -$676K | 0.01% | 1206 |
|
|
2017
Q2 | $42.5M | Buy |
4,818,847
+1,305,298
| +37% | +$9.17M | ﹤0.01% | 1462 |
|
|
2017
Q1 | $22.7M | Buy |
3,513,549
+1,903,355
| +118% | +$9.64M | ﹤0.01% | 1841 |
|
|
2016
Q4 | $5.91M | Buy |
1,610,194
+178,401
| +12% | +$528K | ﹤0.01% | 2596 |
|
|
2016
Q3 | $4.65M | Sell |
1,431,793
-922,939
| -39% | -$2.58M | ﹤0.01% | 2599 |
|
|
2016
Q2 | $5.46M | Buy |
2,354,732
+912,372
| +63% | +$3.05M | ﹤0.01% | 2544 |
|
|
2016
Q1 | $3.61M | Buy |
1,442,360
+130,347
| +10% | +$293K | ﹤0.01% | 2721 |
|
|
2015
Q4 | $4.03M | Buy |
1,312,013
+10,014
| +0.8% | +$28K | ﹤0.01% | 2648 |
|
|
2015
Q3 | $2.24M | Sell |
1,301,999
-13,590
| -1% | -$34.7K | ﹤0.01% | 2949 |
|
|
2015
Q2 | $5.35M | Buy |
1,315,589
+38,251
| +3% | +$156K | ﹤0.01% | 2592 |
|
|
2015
Q1 | $4.89M | Sell |
1,277,338
-1,372
| -0.1% | -$5.97K | ﹤0.01% | 2575 |
|
|
2014
Q4 | $6.14M | Buy |
1,278,710
+3,687
| +0.3% | +$14.6K | ﹤0.01% | 2468 |
|
|
2014
Q3 | $4.74M | Sell |
1,275,023
-22,275
| -2% | -$75.3K | ﹤0.01% | 2574 |
|
|
2014
Q2 | $4.74M | Sell |
1,297,298
-12,054
| -0.9% | -$44.3K | ﹤0.01% | 2628 |
|
|
2014
Q1 | $5.51M | Buy |
1,309,352
+42,919
| +3% | +$213K | ﹤0.01% | 2519 |
|
|
2013
Q4 | $5.83M | Buy |
1,266,433
+20,282
| +2% | +$90.3K | ﹤0.01% | 2495 |
|
|
2013
Q3 | $7.71M | Buy |
1,246,151
+27,690
| +2% | +$159K | ﹤0.01% | 2263 |
|
|
2013
Q2 | $6.63M | Buy |
+1,218,461
| New | +$4M | ﹤0.01% | 2294 |
|
State Street's IMMU Position: Q4 2020 in Review
State Street sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,648,078 shares — an estimated $310M sold.
State Street first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $310M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- State Street reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- State Street sold 3,648,078 Immunomedics Inc shares in Q4 2020, an estimated $310M.
- State Street first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- State Street's Immunomedics Inc position peaked at $310M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.